Scientists scan brains to track new Drug's journey
NCT ID NCT05470101
Summary
This early study aimed to understand how a new drug called ITI-333 works in the brain. Researchers gave single doses to 12 healthy volunteers and used special brain scans to see how much of the drug attached to its target. They also checked how the body processed the drug and monitored for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 1
St Louis, Missouri, 63110, United States
-
Clinical Site 2
Creve Coeur, Missouri, 63141, United States
Conditions
Explore the condition pages connected to this study.